Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
534.00
-19.15 (-3.46%)
Nov 3, 2026, 2:03 PM EST - Market open

Vertex Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
3,4413,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,073
Revenue Growth
11.85%12.45%7.82%9.55%10.98%12.06%2.96%15.66%11.61%6.11%13.30%9.34%6.39%13.52%13.22%11.10%17.65%22.46%21.64%27.32%
Gross Profit
2,9151,8511,6331,7501,6841,5791,4281,4901,5031,3071,5591,3251,3551,3991,3651,3251,4001,3471,2511,257
Operating Income
7501,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,002
Net Income
653.61,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1
Earnings Per Share
2.564.314.024.654.203.992.493.504.01-13.924.213.713.973.522.693.143.593.132.962.99
EPS Growth
-39.05%8.02%61.45%32.88%4.74%--40.86%-5.64%1.01%-56.51%18.08%10.59%12.46%-9.12%5.02%9.45%1109.96%18.88%30.38%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Trikafta / Kaftrio
2,4372,4972,3552,5732,6542,5512,5362,7212,5852,4492,4842,3332,2742,2402,0972,0222,0111,8931,7621,693
Alyftrek
705.8573.6424.4380.1247156.853.9-------------
Casgevy
99.276.442.954.316.930.414.282-----------
Journavx
58.349.62926.719.6121.3-------------
Other
140.6137.1135.9156.4139.3214.4165.3183.2184.9196.4207184.4209.2252.8278.1281.2323.8303335.9379.6
Revenue (Total)
3,4413,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,073

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
9,82113,64212,99712,32012,01012,02911,35811,22411,22810,18914,55313,71613,62812,59411,49610,8919,7719,2538,2387,525
Total Debt
6,4781,9781,9872,0361,8351,5271,6491,7501,774933.4721.3808.4744.7767.6789.2899.7824.6847.3872.5967.4
Net Cash (Debt)
3,34311,66411,01010,28410,17510,5019,7099,4749,4549,25513,83112,90812,88411,82610,7069,9918,9468,4067,3666,558
Net Cash Growth
-67.15%11.07%13.41%8.55%7.63%13.46%-29.81%-26.60%-26.62%-21.74%29.19%29.19%44.01%40.68%45.36%52.36%47.04%44.58%22.25%14.71%
Net Cash Per Share
13.1045.7042.9640.1639.5040.5637.4136.3736.2235.8652.9749.4749.4445.4141.1338.3834.4732.4928.5625.52

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-1,1251,4284981,2411,073818.9584.61,370-3,7541,307234.61,2681,134899.91,078955.51,140956.2995
Capital Expenditures
--112.2-133.4-149.4-101.8-145.7-40.7-92.6-67.7-69-68.4-58.1-40.6-59.6-42.1-33.6-54.2-53.3-63.6-61.8
Free Cash Flow
-1,0131,295348.61,140927.4778.24921,302-3,8231,238176.51,2281,075857.81,045901.31,087892.6933.2
Free Cash Flow Growth
-9.25%66.37%-29.15%-12.48%--37.15%178.75%6.05%-44.35%-83.11%36.23%-1.08%-3.90%11.96%3.03%-5.00%110.26%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
84.71%55.52%54.66%54.87%54.74%53.25%51.53%51.16%54.24%49.41%57.94%52.63%54.55%56.11%57.49%57.55%59.97%61.35%59.62%60.67%
Operating Margin
21.80%38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%
Pretax Margin
22.77%41.75%41.95%41.72%42.22%43.28%26.37%39.03%44.16%-128.18%47.54%45.58%47.48%46.59%37.54%46.76%50.40%46.64%45.52%42.02%
Profit Margin
19.00%32.99%34.53%37.34%35.20%34.84%23.33%31.35%37.71%-135.83%40.87%38.48%41.69%36.73%29.47%35.56%39.86%36.91%36.33%37.16%
FCF Margin
-30.39%43.35%10.93%37.04%31.28%28.09%16.90%46.98%-144.49%46.02%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.55%45.03%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
33.3328.6226.1529.1027.3231.43----26.8628.9725.8726.9424.8522.3122.6922.5627.1123.84
Forward PE
38.1925.3623.3122.6120.3223.6026.8822.6626.3928.0724.8524.4421.9222.7021.8918.8319.6719.4518.1216.42
P/FCF Ratio
-33.2130.5736.0230.0932.67----29.0531.4221.3423.3720.8218.8919.4719.0327.1123.18
PS Ratio
10.2310.029.289.588.5710.0111.229.4111.3011.7010.6010.629.309.548.808.308.548.638.367.37